title: Evidence that the risks of misoprostol outweigh its benefits in stable cyclosporine-treated renal allograft recipients.
authors.affiliation: Department of Nephrology, Royal London Hospital, London Hospital Medical College, Whitechapel, United Kingdom.
authors.forename: M E
authors.initials: ME
authors.lastname: Wilkie
authors.forename: J C
authors.initials: JC
authors.lastname: Beer
authors.forename: D
authors.initials: D
authors.lastname: Newman
authors.forename: M J
authors.initials: MJ
authors.lastname: Raftery
authors.forename: F P
authors.initials: FP
authors.lastname: Marsh
mesh_terms: D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016595:Misoprostol / Q000009:adverse effects*; D012307:Risk Factors; D014184:Transplantation, Homologous
chemical_list: D016595:Misoprostol; D016572:Cyclosporine